Dr. Martin Joyce-Brady, MD
725 Albany Street, Shapiro, Suite B, Boston, MA 02118 • +1-425-555-5176
Medical Education: Accredited U.S. Medical School (Class of 2009)
What This Doctor Actually Performs: CMS Medicare Utilization & Boston Percentiles
NPI #1891753182 • CBSA 14460 • Critical Care (Intensivists)
Dr. Martin Joyce-Brady, MD (NPI #1891753182) practices Critical Care (Intensivists) in Boston, MA (02118) with sub-specialty concentration in 22 Active CMS HCPCS Codes, recording 805 annual CMS services across 503 distinct beneficiaries—placing this practice as a mid-cohort balanced caseload (50th Boston percentile) (-0.57σ vs MA state mean, 31.82th statewide percentile).
Granular CPT/HCPCS billing distribution at 725 Albany Street, Shapiro, Suite B shows Dr. Martin Joyce-Brady's primary concentration in Moderate-to-High Complexity Internal Medicine Follow-Up (code 99214: 351x/yr, 50th local percentile) alongside Established Preventive & Chronic Care Visit (99213: 203x/yr, $177–$242).
Cash-pay intake data for NPI 1891753182 (725 Albany Street, Shapiro, Suite B, Boston) indicates $227.00 typical out-of-pocket visit spend against a $227.00 locality benchmark, paired with 20-minute average reception wait and 4.68/5 biomarker openness.
Spanning 17 years of clinical practice following 2009 graduation from medical training, Dr. Martin Joyce-Brady integrates 22 Active CMS HCPCS Codes diagnostics for Boston metro patients.
Compared against Boston, MA Critical Care (Intensivists) peers
805 annual services across 503 beneficiaries
Standard deviations from MA Critical Care (Intensivists) mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 351 | 50th | $231 – $316 |
| 99213 | Established Preventive & Chronic Care Visit | 203 | 47th | $177 – $242 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 101 | 54th | $84 – $116 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 78 | 53th | $271 – $371 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 47 | 48th | $321 – $440 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (22 HCPCS billing breadth) | 25 | 50th | $208 – $302 |
Are you Dr. Martin Joyce-Brady? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Boston, MA:
<a href="https://dotmd.com/doctors/martin-joyce-brady-md-boston-ma-1891753182" title="Dr. Martin Joyce-Brady, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1891753182.svg" alt="Dr. Martin Joyce-Brady Critical Care (Intensivists) Badge" width="280" height="72" /></a>
Dr. Martin Joyce-Brady, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Joyce-Brady National Provider Identifier | NPI #1891753182 (MD) | CMS NPPES Registry (02118) |
| Dr. Joyce-Brady Boston CMS Volume Rank | 50.00th Pct (805 CMS svcs; Z -0.573σ) | CMS Medicare Part B (MA Critical Care (Intensivists)) |
| Fair Cash-Pay New-Patient Benchmark | $227.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Boston, MA) |
| Waiting-Room Wait Time & Cash Friendliness | $227.00 avg paid • 20 min lobby wait | 26 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.87/5 Listening • 4.68/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Martin Joyce-Brady
Other High-Volume Critical Care (Intensivists) Specialists in Boston, MA
Ranked strictly by CMS Medicare volumeDr. Joyce-Brady Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Boston, MA.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Martin Joyce-Brady community threads and patient logs by age, biological sex, dosage, and treatment duration.